Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynne Uhl

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Transfusion|October 25, 2016
Hemovigilance in Massachusetts and the adoption of statewide hospital blood bank reporting using the National Healthcare Safety NetworkMelissa Cumming, Anthony Osinski, Lynne O'Hearn, et al.
Transfusion|May 26, 2025
Determinants and clinical impact of time to plasma exchange in patients with immune thrombotic thrombocytopenic purpuraIshan J Tatake, Shelby C Wilkinson, Kristen N Ruby, et al.
Therapeutic Advances in Hematology|October 21, 2017
Red cell genotyping precision medicine: a conference summaryGregory A Denomme, Waseem Q Anani, Neil D Avent, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responsesDavid Avigan, Baldev Vasir, Jianlin Gong, et al.
Archives of Pathology & Laboratory Medicine|March 15, 2021
Heterogeneity in Approaches for Switching From Universal to Patient ABO Type-Specific Blood Components During Massive HemorrhageMatthew S Karafin, Joanne L Becker, Mary Berg, et al.
Blood|October 30, 2010
Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myelomaJacalyn Rosenblatt, Baldev Vasir, Lynne Uhl, et al.
The Lancet. Haematology|March 6, 2017
Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort studyPavan K Bendapudi, Shelley Hurwitz, Ashley Fry, et al.
American Heart Journal|January 18, 2025
Individualized transfusion decisions to minimize adverse cardiovascular outcomes in patients with acute myocardial infarction and anemiaGerard T Portela, Gregory Ducrocq, Marnie Bertolet, et al.
American Journal of Hematology|April 8, 2017
Clinical outcomes in a cohort of patients with heparin-induced thrombocytopeniaDavid J Kuter, Barbara A Konkle, Taye H Hamza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2013
Vaccination with dendritic cell/tumor fusions following autologous stem cell transplant induces immunologic and clinical responses in multiple myeloma patientsJacalyn Rosenblatt, Irit Avivi, Baldev Vasir, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Transfusion|October 25, 2016
Hemovigilance in Massachusetts and the adoption of statewide hospital blood bank reporting using the National Healthcare Safety NetworkMelissa Cumming, Anthony Osinski, Lynne O'Hearn, et al.
Transfusion|May 26, 2025
Determinants and clinical impact of time to plasma exchange in patients with immune thrombotic thrombocytopenic purpuraIshan J Tatake, Shelby C Wilkinson, Kristen N Ruby, et al.
Therapeutic Advances in Hematology|October 21, 2017
Red cell genotyping precision medicine: a conference summaryGregory A Denomme, Waseem Q Anani, Neil D Avent, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responsesDavid Avigan, Baldev Vasir, Jianlin Gong, et al.
Archives of Pathology & Laboratory Medicine|March 15, 2021
Heterogeneity in Approaches for Switching From Universal to Patient ABO Type-Specific Blood Components During Massive HemorrhageMatthew S Karafin, Joanne L Becker, Mary Berg, et al.
Blood|October 30, 2010
Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myelomaJacalyn Rosenblatt, Baldev Vasir, Lynne Uhl, et al.
The Lancet. Haematology|March 6, 2017
Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort studyPavan K Bendapudi, Shelley Hurwitz, Ashley Fry, et al.
American Heart Journal|January 18, 2025
Individualized transfusion decisions to minimize adverse cardiovascular outcomes in patients with acute myocardial infarction and anemiaGerard T Portela, Gregory Ducrocq, Marnie Bertolet, et al.
American Journal of Hematology|April 8, 2017
Clinical outcomes in a cohort of patients with heparin-induced thrombocytopeniaDavid J Kuter, Barbara A Konkle, Taye H Hamza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2013
Vaccination with dendritic cell/tumor fusions following autologous stem cell transplant induces immunologic and clinical responses in multiple myeloma patientsJacalyn Rosenblatt, Irit Avivi, Baldev Vasir, et al.
Pageof 5